Trial Profile
An open-label study of the effect of repeated cycles of intravenous Epothilone D on treatment response in patients with hormone-resistant prostate cancer who have progressed following initial therapy for metastatic disease.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 Feb 2010
Price :
$35
*
At a glance
- Drugs Epothilone D (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- Sponsors Roche
- 26 Feb 2010 New trial record